Media-OutReach Newswire Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire Uni-Bio Science Group and Medlink Builds Strategic Partnership Expansion of Value Chain towards Pharmaceutical E-commerce
Media-OutReach Newswire Collaboration between Uni-Bio Science Group and Swiss company Ypsomed to jointly develop 2nd generation diabetes and osteoporosis products